Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes.

Annie H RenPanagiota S FilippouAntoninus SoosaipillaiLampros DimitrakopoulosDimitrios KorbakisFelix LeungVathany KulasingamMarcus Q BernardiniEleftherios P Diamandis

Published in: Clinical chemistry and laboratory medicine (2022)

We report the novel role of MUC13 as a serum ovarian cancer biomarker, where it could complement CA125 for detecting some subtypes of non-serous ovarian carcinoma and early-stage disease.

Keyphrases

high grade
early stage
protein kinase
loop mediated isothermal amplification
squamous cell carcinoma
label free
real time pcr
human health
radiation therapy
risk assessment